Janumet xr and Dysphagia aggravated - a phase IV clinical study of FDA data

Summary:

Dysphagia aggravated is reported as a side effect among people who take Janumet xr (metformin hydrochloride; sitagliptin phosphate), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Januvia, and have Appetite - decreased.

The phase IV clinical study analyzes which people have Dysphagia aggravated when taking Janumet xr. It is created by eHealthMe based on reports of 2,311 people who have side effects when taking Janumet xr from the FDA, and is updated regularly.

What is Janumet xr?

Janumet xr has active ingredients of metformin hydrochloride; sitagliptin phosphate. It is often used in type 2 diabetes. eHealthMe is studying from 2,357 Janumet xr users. Check the latest studies of Janumet xr.

What is Dysphagia aggravated?

Dysphagia aggravated (serious condition in which swallowing is difficult or painful) is found to be associated with 1,718 drugs and 585 conditions by eHealthMe. Check the latest studies of Dysphagia aggravated.

On Jul, 07, 2026

2,311 people reported to have side effects when taking Janumet xr.
Among them, 26 people (1.13%) have Dysphagia aggravated.

Could Janumet xr cause Dysphagia aggravated?

Among these 26 people:

How long have people been on Janumet xr when they have Dysphagia aggravated? *

What is the gender of people who have Dysphagia aggravated when taking Janumet xr? *

female: 50 %
male: 50 %

What is the age of people who have Dysphagia aggravated when taking Janumet xr? *

What are other drugs people take besides Janumet xr? *

What are other side effects people have besides Dysphagia aggravated? *

Acute Upper Airway Obstruction (blockage occurs in the upper airway): 5 people, 19.23%
Insomnia (sleeplessness): 3 people, 11.54%
Fall: 3 people, 11.54%
Nausea (feeling of having an urge to vomit): 2 people, 7.69%
Confusional State: 2 people, 7.69%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 7.69%
Body Height Decreased: 2 people, 7.69%
Fear: 2 people, 7.69%
Speech Impairment (Adult) (inability to speak (adult)): 2 people, 7.69%
Stress And Anxiety: 2 people, 7.69%

What are the existing conditions these people have? *

High Blood Pressure: 2 people, 7.69%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 7.69%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 7.69%
Microalbuminuria (albumin into the urine): 1 person, 3.85%
Hypersensitivity: 1 person, 3.85%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Janumet xr and have Dysphagia aggravated?

- Check whether Dysphagia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Janumet xr:

Janumet xr (2,357 reports)

Dysphagia aggravated treatments and more:

Dysphagia aggravated (9 reports)

How severe was Dysphagia aggravated and when was it recovered:

Dysphagia aggravated in Janumet xr

Expand to all the drugs that have ingredients of metformin hydrochloride; sitagliptin phosphate:

Dysphagia aggravated and drugs with ingredients of metformin hydrochloride; sitagliptin phosphate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Janumet xr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysphagia aggravated:

Dysphagia aggravated (1,718 drugs)

Browse all the conditions that are associated with Dysphagia aggravated:

Dysphagia aggravated (585 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on metformin hydrochloride; sitagliptin phosphate (the active ingredients of Janumet xr) and Janumet xr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.